Register Now

Overview

This talk will delve into new and emerging cardiovascular risk assessment tools that can be used to better personalize a patient’s cardiovascular risk and help direct individualized therapy. It will also review upcoming therapies that aim to address this residual risk.

Click here to answer audience response questions, access downloadable slides, and ask questions to the presenter.

Learning Objectives

  • Define residual cardiovascular disease risk and its role in personalized medicine
  • Identify the factors associated with residual cardiovascular disease risk
  • Discuss current tools and therapies that identify and tackle residual cardiovascular risk
  • Recognize therapies currently under investigation that address residual cardiovascular risk